Table 1.

Inhibition of SIV replication by soluble antiviral factors from sequential PBMCs of PMPA-treated/infused monkeys and control monkeys

0 wk after infection8 wk after infection22 wk after infection42 wk after infection
 Pre SIV p27
(% inhibition) 
Pre PMPA p27
(% inhibition) 
1 wk after infusion p27
(% inhibition) 
23 wk after infusion p27
(% inhibition)  
Targets alone 144.6    
RM1a 123.4  (14.7) 44.3  (69.4) 75.8  (47.6) 90.9  (37.1) 
RM1b 127.9  (11.5) 33.9  (76.6) 81.2  (43.8) 102.3  (29.3)  
RM3a 118.6  (18.0) 51.4  (64.5) 0.9  (99.4) 12.7  (91.2) 
RM3b 126.0  (12.9) 42.9  (70.3) 1.1  (99.2) 3.2  (97.8) 
RM3c 132.2  (8.6) 47.6  (67.1) 24.4  (83.1) 78.8  (45.5) 
RM4a 125.4  (13.3) 36.9  (74.5) 32.2  (77.7) 31.1  (78.5)  
RM4b 116.5  (19.4) 38.9  (73.1) 47.5  (67.2) 45.5  (68.5)  
RM4c 132.3  (8.5) 41.1  (71.6) 38.8  (73.2) 32.8  (77.3) 
0 wk after infection8 wk after infection22 wk after infection42 wk after infection
 Pre SIV p27
(% inhibition) 
Pre PMPA p27
(% inhibition) 
1 wk after infusion p27
(% inhibition) 
23 wk after infusion p27
(% inhibition)  
Targets alone 144.6    
RM1a 123.4  (14.7) 44.3  (69.4) 75.8  (47.6) 90.9  (37.1) 
RM1b 127.9  (11.5) 33.9  (76.6) 81.2  (43.8) 102.3  (29.3)  
RM3a 118.6  (18.0) 51.4  (64.5) 0.9  (99.4) 12.7  (91.2) 
RM3b 126.0  (12.9) 42.9  (70.3) 1.1  (99.2) 3.2  (97.8) 
RM3c 132.2  (8.6) 47.6  (67.1) 24.4  (83.1) 78.8  (45.5) 
RM4a 125.4  (13.3) 36.9  (74.5) 32.2  (77.7) 31.1  (78.5)  
RM4b 116.5  (19.4) 38.9  (73.1) 47.5  (67.2) 45.5  (68.5)  
RM4c 132.3  (8.5) 41.1  (71.6) 38.8  (73.2) 32.8  (77.3) 

SIV indicates simian immunodeficiency virus; PBMCs, peripheral blood mononuclear cells; and PMPA, 9-R-(2-phosphonylmethoxypropyl) adenine.

p27 values expressed in ng/mL of supernatant fluid (% inhibition from cultures with targets only).

P < .04.

Close Modal

or Create an Account

Close Modal
Close Modal